Details for New Drug Application (NDA): 084772
✉ Email this page to a colleague
NDA 084772 describes PROMETH FORTIS, which is a drug marketed by Alpharma Us Pharms and is included in one NDA. Additional details are available on the PROMETH FORTIS profile page.
The generic ingredient in PROMETH FORTIS is promethazine hydrochloride. There are twelve drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
The generic ingredient in PROMETH FORTIS is promethazine hydrochloride. There are twelve drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
Summary for 084772
| Tradename: | PROMETH FORTIS |
| Applicant: | Alpharma Us Pharms |
| Ingredient: | promethazine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084772
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 25MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
